Emmaus Life Sciences, Inc. (EMMA) › Total AssetsEmmaus Life Sciences, Inc. (EMMA) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $237.5K2011: $370.0K2012: $125.3K2013: $1.40M2014: $1.34M2015: $567.1K2016: $512.1K2017: $6.10M2018: $75.28M2019: $59.46M2020: $59.54M2021: $56.73M2022: $48.23M2023: $35.18M2024: $23.60M2025: $21.44M$21.44M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$21.44M-9.2%2024$23.60M-32.9%2023$35.18M-27.1%2022$48.23M-15.0%2021$56.73M-4.7%2020$59.54M+0.1%2019$59.46M-21.0%2018$75.28M+1134.9%2017$6.10M+1090.4%2016$512.1K-9.7%2015$567.1K-57.6%2014$1.34M-4.7%2013$1.40M+1019.1%2012$125.3K-66.1%2011$370.0K+55.8%2010$237.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share